LONDON (Thomson Financial) - ReNeuron Group PLC said it welcomes today’s vote by the European Parliament to create a regulatory framework and single European marketing authorisation for gene therapy, cell therapy and tissue engineered products.
LONDON (Thomson Financial) - ReNeuron Group PLC said it welcomes today’s vote by the European Parliament to create a regulatory framework and single European marketing authorisation for gene therapy, cell therapy and tissue engineered products.
